Company: SQFTP
Filing Date: 2025-10-14
Form Type: 424B5
Source: 0001493152-25-018010
Chunk: 13

Company: Presidio Property Trust, Inc.
Filing Date: 2025-10-14
Form: 424B5
Chunk 13
---
 S-12 of this prospectus                                 
 supplement                                                                                                                            |
| Use                                                                  
 of proceeds                                                          |     | We                                                                                                                                    
 currently intend to use the estimated net proceeds from the sale of our shares in this offering for working capital and other general 
 corporate purposes, including to potentially acquire additional properties, though no such acquisitions are currently contemplated.   
 See “Use of Proceeds” on page S-11.                                                                                                   |
| Market                                                               
 for common stock                                                     |     | Our                                                                                                                                   
 common stock is listed on The Nasdaq Capital Market under the symbol “SQFT.”                                                          |
| Risk                                                                 
 factors                                                              |     | An                                                                                                                                    
 investment in our common stock involves significant risks. Before making an investment in our common stock, you should carefully      
 review the “Risk Factors” section below, and the risk factors stated in the accompanying prospectus, as well as the other             
 documents incorporated by reference into this prospectus supplement and the accompanying prospectus.                                  |

(1) The number of shares of common stock to be outstanding immediately after this offering is based on 1,439,099 issued and outstanding shares as of October 14, 2025. This number excludes the following:

● 200,000 shares of our common stock that are issuable upon exercise of outstanding warrants with an exercise price of $12.00 per share;

● 8,000 shares of our common stock that are issuable upon exercise of outstanding warrants with an exercise price of $62.50 per share; and

● 23,494 shares of our common stock which are reserved for equity awards that may be granted under our equity incentive plan.

| S-9 |

<div align='center'>RISK FACTORS</div>

You should carefully consider the risk factors described in the accompanying prospectus, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and in our subsequent quarterly reports, as well as the other information contained or incorporated by reference in this prospectus supplement and the accompanying prospectus, and the risk factors set forth below before deciding to invest in shares of our common stock. Such risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. The occurrence of any of the events or actions described in these risk factors may have a material adverse effect on our business or financial performance.

<div align='center'>Risks Related to this Offering</div>

It is not possible